Literature DB >> 30255238

Immunoglobulin A nephropathy secondary to Wilson's disease: a case report and literature review.

Yoshinosuke Shimamura1, Takuto Maeda2, Yufu Gocho2, Yayoi Ogawa3, Kunihiko Tsuji4, Hideki Takizawa2.   

Abstract

Immunoglobulin A nephropathy is the most common primary glomerulonephritis worldwide, and it can be associated with liver disease. However, cases of Immunoglobulin A nephropathy secondary to Wilson's disease are very rare. A 20-year-old Japanese man presented with microscopic hematuria, proteinuria, and renal dysfunction. A renal biopsy showed mesangial cell proliferation, immunoglobulin A deposition, and electron-dense deposit in the mesangial areas, all of which are consistent with Immunoglobulin A nephropathy. Computed tomography of the abdomen showed liver atrophy and splenomegaly, and the diagnosis of Wilson's disease was confirmed with decreased serum ceruloplasmin levels, increased urinary copper excretion, Kayser-Fleischer rings and copper deposition in the liver biopsy. The patient was treated successfully with trientine hydrochloride and zinc acetate and showed improvement in renal manifestations. Wilson's disease is a rare cause of secondary Immunoglobulin A nephropathy. We recommend that Wilson's disease should be considered the cause of secondary Immunoglobulin A nephropathy in juvenile patients with hematuria, proteinuria, and splenomegaly and suggest measuring the serum ceruloplasmin concentrations, urinary copper excretion, and evaluating Kayser-Fleischer rings in these patients.

Entities:  

Keywords:  IgA nephropathy; Trientine hydrochloride; Wilson’s disease; Zinc acetate

Mesh:

Substances:

Year:  2018        PMID: 30255238      PMCID: PMC6361083          DOI: 10.1007/s13730-018-0365-7

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN: 2192-4449


  1 in total

1.  Nephrotic range proteinuria in an adolescent with a diagnosis of Wilson's disease: Answers.

Authors:  Ayşe Ağbaş; Eda Dilara Bay; Meryem Keçeli Başaran; Türkan İkizceli; Gözde Kılıç Kayhan; Yasemin Özlük
Journal:  Pediatr Nephrol       Date:  2021-02-02       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.